Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |